Market Cap
Thermo Fisher Scientific Inc.
$204.45 Billion
USD as of July 1, 2024
Company | Market Cap (USD) |
---|---|
Danaher | $177.21 B |
Siemens Healthineers AG | $63.84 B |
DexCom, Inc. | $45.21 B |
Lonza Group Ltd | $39.85 B |
IDEXX Laboratories, Inc. | $39.43 B |
Company | Market Cap (USD) |
---|---|
Lilly | $808.65 B |
Novo Nordisk | $622.07 B |
UnitedHealth Group | $450.89 B |
Johnson & Johnson | $350.63 B |
Merck | $318.75 B |
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Thermo Fisher Scientific Inc. dedicated to biological and medical diagnostics and research. It manufactures and distributes scientific and medical instruments, laboratory equipment, software, reagents, consumables, chemicals, and services. Segmented into life sciences, analytical instruments, specialty diagnostics, and laboratory products, Thermo Fisher caters to the needs of multiple pharmaceuticals, biotechnology, agricultural, clinical, academic, and government actors.
The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.